Filter Results :

Your search for antibod returned 146 reports

Sort by


Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

18 Aug 2016  |  Published by:  MarketsandMarkets
The antibody production market is projected to reach USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market comprises products required during the different stages of bioprocessing of antibodies, su...

$ 5,650.00

Read More

United States Monoclonal Antibody Market Report 2021

10 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Monoclonal Antibody in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Affymetrix Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad Cepheid Diamedix/Erba DiaSorin ...

$ 3,800.00

Read More

Anti GM-CSF Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti GM-CSF Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre...

$ 1,250.00

Read More

Anti-CD105 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD105 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD105 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-c...

$ 1,250.00

Read More

Anti-CD152 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD152 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD152 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-c...

$ 1,250.00

Read More

Anti-CD19 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD19 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD19 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD22 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD22 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD22 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD25 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD25 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD25 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD274 (PD-L1) Antibody. The DelveInsights Report covers the product profiles in various stages of development including ...

$ 1,250.00

Read More

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD279 (PD-1) Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD279 (PD-1) Antibody. The DelveInsights Report covers the product profiles in various stages of development including Di...

$ 1,250.00

Read More

Anti-CD28 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD28 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD28 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD3 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD3 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD3 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

Anti-CD30 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD30 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD30 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD33 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD33 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD33 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD37 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD37 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD37 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More
Total 146 records.